thiamphenicol has been researched along with sulfisoxazole in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Rütte, B | 1 |
Gsell, O; Steffen, R | 1 |
1 trial(s) available for thiamphenicol and sulfisoxazole
Article | Year |
---|---|
Prophylaxis of traveller's diarrhoea.
Topics: Adolescent; Adult; Aged; Antidiarrheals; Clinical Trials as Topic; Diarrhea; Double-Blind Method; Drug Combinations; Ethacridine; Humans; Middle Aged; Nitrofurantoin; Phenindione; Random Allocation; Streptomycin; Sulfadiazine; Sulfadoxine; Sulfamethazine; Sulfathiazoles; Sulfisoxazole; Thiamphenicol; Travel | 1981 |
2 other study(ies) available for thiamphenicol and sulfisoxazole
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[The importance of the combinations therapy in the treatment of acute urinary tract infections (author's transl)].
Topics: Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Humans; Nitrofurantoin; Sulfisoxazole; Thiamphenicol; Urinary Tract Infections | 1976 |